NCT07771985

Brief Summary

This randomized controlled study aimed to compare the effects of under running water bathing and underrunning water bathing combined with massage on bilirubin levels in term newborns receiving phototherapy. The study was conducted between June 2024 and March 2025 in the neonatal clinic of Kayseri City Hospital after obtaining institutional permission, ethics approval, and informed consent from the families. Ninety term newborns were randomly assigned to three groups:under running water bathing, under running water bathing +massage, and control (routine care). Bilirubin levels were measured before phototherapy and at the 12th and 24th hours. While bilirubin levels decreased over time in all groups, the underrunning water bathing combined massage group had significantly lower bilirubin levels than the control group at the 24th hour. The use of a underrunning water bath and massage combination is recommended as part of nursing care for term newborns receiving phototherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

March 16, 2026

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
Last Updated

August 19, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

March 16, 2026

Last Update Submit

August 17, 2026

Conditions

Keywords

Underrunning water bathMassageNewbornNursePhototherapy

Outcome Measures

Primary Outcomes (1)

  • Total Serum Bilirubin Level Unit of Measure: mg/dL

    Total serum bilirubin levels of term newborns receiving phototherapy will be measured to evaluate the effects of under-running water bathing and under-running water bathing combined with massage compared with a control group. Unit of Measure: mg/dL

    Baseline (before initiation of phototherapy), 12 hours after initiation of phototherapy, and 24 hours after initiation of phototherapy

Secondary Outcomes (4)

  • Heart Rate-Unit of Measure: Beats/min.

    T0 (baseline before initiation of phototherapy), T20 (20 minutes after baseline), T12 (12 hours after initiation of phototherapy), and T24 (24 hours after initiation of phototherapy).

  • Oxygen Saturation- Unıt of Measure %

    T0 (baseline before initiation of phototherapy), T20 (20 minutes after baseline), T12 (12 hours after initiation of phototherapy), and T24 (24 hours after initiation of phototherapy).

  • Body Temperature-Unıt of Measure °C

    T0 (baseline before initiation of phototherapy), T20 (20 minutes after baseline), T12 (12 hours after initiation of phototherapy) , and T24 (24 hours after initiation of phototherapy).

  • Respiratory Rate- Unıt of Measure Breaths/min

    T0, T20, T12, and T24 .

Study Arms (3)

Underrunning Water Bathing Group

EXPERIMENTAL

Term newborns receiving phototherapy will receive a underrunning water bathing before phototherapy as a nursing intervention.

Other: Underrunning Water Bathing

Underrunning Water Bathing + Massage Group

EXPERIMENTAL

Term newborns receiving phototherapy will receive a underrunning water bathing followed by massage before phototherapy.

Other: Underrunning Water Bath + Massage Combination

Control Group

NO INTERVENTION

Term newborns receiving phototherapy will receive routine clinical care without additional intervention.

Interventions

Following the baseline (T0) assessment, term newborns received an approximately 5-minute bath under running water as a supportive nursing intervention before the initiation of phototherapy. After the intervention, a second assessment of vital signs (T20) was performed, and phototherapy was subsequently initiated.Vital signs were reassessed at 12 and 24 hours after phototherapy initiation. Total serum bilirubin levels were measured at baseline (T0) and at 12 and 24 hours after phototherapy initiation.

Underrunning Water Bathing Group

Term newborns received a 5-minute bath under running water followed by a 15-minute massage as a supportive nursing intervention after the baseline (T0) assessment and before the initiation of phototherapy. Following the intervention, a second vital sign assessment (T20) was performed, phototherapy was subsequently initiated.Vital signs were reassessed at 12 and 24 hours after phototherapy initiation. Total serum bilirubin levels were measured at baseline (T0) and at 12 and 24 hours after phototherapy initiation.

Underrunning Water Bathing + Massage Group

Eligibility Criteria

Age38 Weeks - 42 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Term newborns with a gestational age between 38 and 42 weeks.
  • Birth weight of 2500 g or higher.
  • Newborns diagnosed with physiological hyperbilirubinemia.
  • Newborns receiving phototherapy treatment.
  • Postnatal age between 2 and 10 days.
  • No congenital anomalies.
  • No additional health problems.
  • Apgar score ≥7 at the 1st minute after birth.
  • Stable vital signs.

You may not qualify if:

  • Birth weight ≤2500 g.
  • Gestational age less than 38 weeks.
  • Pathological jaundice (e.g., ABO incompatibility, Rh incompatibility, biliary atresia, glucose-6-phosphate dehydrogenase deficiency, or glucuronyl transferase enzyme deficiency).
  • Inability to feed orally.
  • Postnatal age on the first day of life.
  • Receiving blood transfusion therapy.
  • Newborns with secondary conditions such as asphyxia or infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kayseri City Hospital, Neonatal Intensive Care Unit

Kayseri, Merkez, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hyperbilirubinemia, Neonatal

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ayşe ŞENER TAPLAK, Associate Professor, PhD

    Yozgat Bozok Unıversty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 16, 2026

First Posted

August 19, 2026

Study Start

June 17, 2024

Primary Completion

March 6, 2025

Study Completion

March 6, 2025

Last Updated

August 19, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to confidentiality concerns and institutional policies regarding data protection.

Locations